Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol versus etomidate for general anesthesia induction in off-pump coronary artery bypass grafting
ChiCTR2300068523Phase 4Recruiting
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Oct 2022
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ciprofol and etomidate in coronary arteriosclerosis (3 arms), sponsored by General Hospital of the Northern Theater Command. Primary endpoint: Area under the curve below baseline mean arterial pressure. Started Oct 2022; status: recruiting.
02
Drugs
ciprofoletomidate
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR2300068523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068523.